Zio XT recommended by NICE in the latest CVD impact report to detect cardiac arrhythmias.

Click here to see the full report
Support
Support
Search

UK Sources

MKT-CLAIMS00079.04

Zio long-term continuous monitoring service was able to capture data for the 51% of patients who had their first symptom-triggered arrhythmia after 48 hours.1-8

Over 50% of arrhythmias may be missed by monitoring with 48hr Holter. 1-8

  1.  Turakhia et al. Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device. The American Journal of Cardiology. 2013;112(4):520-524. doi:https://doi.org/10.1016/j.amjcard.2013.04.017
  2. Zio LTCM device and service refers to Zio XT and Zio monitor device and service.
  3. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
  4. Over 50% of arrhythmias were detected after 48 hours.
  5. Contraindications: Do not use the Zio monitor for critical care patients or for patients with symptomatic episodes where instance variations in cardiac performance could result in immediate danger to the patients or when real-time or in-patient monitoring should be prescribed. (Refer to the Zio monitor Instructions for Use for the full list of contraindications).
  6. Zio monitor and ZEUS are CE-marked.
  7. Please refer to the Clinical Reference Manual for a complete set of instructions and safety information.
  8. Zio XT and ZEUS are UKCA-marked.

 

MKT-CLAIMS00050.04

Zio long-term continuous monitoring (LTCM) service detected 57% more arrhythmia events than 24-hour Holter monitors. 1-4

  1. Barrett et al. Comparison of 24-hour Holter Monitoring with 14-day Novel Adhesive Patch Electrocardiographic Monitoring. The American Journal of Medicine. 2014;127(1):95.e11-95.e17. doi:https://doi.org/10.1016/j.amjmed.2013.10.003
  2. Zio LTCM service refers to Zio XT and Zio monitor service.
  3. Based on previous generation Zio XT device data. Zio monitor utilizes the same operating principles and ECG algorithm. Additional data on file.
  4. Based on the US data.

 

MKT-CLAIMS00066.05

Zio ECG monitors have 99% analyzable time. 1

  1. ZSR data from 1/1/2024 to 12/30/2024 on median analyzable time at 98.6% for both Zio monitor and Zio XT. ZSR data combines both n of Zio monitor and Zio XT under the XT column. 

 

MKT-CLAIMS00055.08

Over 10 million patient reports processed and posted.1

  1. Registration numbers provided by Financial Planning and Analysis (FP&A) from 2017 to Q1 2025.

 

MKT-CLAIMS00096.07

Over 2 billion hours of curated heartbeat data.1

  1. Data on file. iRhythm Technologies, 2024.
  2. Based on the US and UK data using Zio® ECG monitors.

 

MKT-CLAIMS00100.04

The iRhythm monitoring service utilizes ZEUS, advanced CE-marked and FDA-cleared deep learned algorithm clinically proven to be as accurate as cardiologists. 1-4
The iRhythm monitoring service utilizes advanced UKCA-marked deep learned algorithm clinically proven to be as accurate as cardiologists. 1-4

  1. Data on file. iRhythm Technologies 2020.
  2. Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69. https://doi.org/10.1038/s41591-018-0268-3
  3. Deep learned algorithm is only available in the United States, European Union, Switzerland, United Kingdom, and Japan. ​
  4. FDA 510K clearance, CE mark, UKCA mark, and PMDA-approval.

 

MKT-CLAIMS00119.04

Physicians agree with the Zio service's comprehensive end-of-wear report 99% of the time. 1-3

  1. Based on a review of all online Zio XT, Zio monitor, and Zio AT end-of-wear reports. Data on file. iRhythm Technologies, 2023.
  2. Based on the US data.
  3. Zio service provides continuous, uninterrupted recording and a comprehensive end-of-wear report

WEB0227.01